Lamsil

Terbinafine, the active ingredient in Lamsil, is a allylamine antifungal presented as a topical formulation for skin use. It treats dermatophyte infections such as athlete's foot, ringworm and jock itch in adults and children.\n\nGNH India supplies Lamsil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terbinafine is an allylamine antifungal used to treat superficial fungal infections of the skin.\n\nTinea corporis: reduces the fungal load and clears the ring‑shaped rash.\nTinea pedis: alleviates itching and scaling on the feet.\nTinea cruris: resolves redness and irritation in the groin area.

Terbinafine is generally well tolerated when applied to intact skin, but local reactions may occur.\n\nCommon Side Effects:\n- Burning sensation at the application site\n- Itching or pruritus\n- Redness or erythema\n- Dryness or scaling of the skin\n- Mild irritation or stinging\n- Peeling of the treated area\n\nSerious or Rare Side Effects:\n- Allergic contact dermatitis\n- Severe skin reactions such as Stevens‑Johnson syndrome\n- Urticaria or hives\n- Angioedema\n- Systemic absorption leading to liver enzyme elevation\n- Unexplained fever or malaise

Before using Lamsil, consider the following safety measures.\n\nPregnancy: consult a healthcare professional; safety not established.\nBreastfeeding: avoid application on broken skin; seek medical advice.\nAge: not recommended for children under 2 years unless directed by a clinician.\nConcurrent topical antifungals: avoid overlapping applications to reduce irritation risk.\nOpen wounds or mucous membranes: do not apply to these areas.\nStore at room temperature: keep in the original container, protect from moisture and direct sunlight.

Terbinafine applied topically has limited systemic interactions, but caution is advised with certain co‑administered agents.\n\nMajor Interactions (Avoid):\n- Systemic antifungals (e.g., itraconazole): may increase systemic exposure if large skin areas are treated.\n- Strong CYP450 inhibitors: avoid extensive use to prevent potential systemic accumulation.\n\nModerate Interactions (Monitor Closely):\n- Alcohol consumption: monitor for rare liver effects with extensive absorption.\n- Other topical medications: may increase local irritation when combined.\n- Phototherapy: observe for heightened skin sensitivity.